K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · COR
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | COR | CENCORA INC. | CENCORA, INC. | $1.1M | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under CMS FY 2026 Medicare's Part B physician fee schedule. Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and Mitigating Generic Drug Shortages CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile |
| 2026-04-20 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Issues related to health care and pharmaceutical industry |
| 2026-04-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2027 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines. |
| 2026-04-20 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $50K | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) |
| 2026-04-20 | COR | CENCORA | MONUMENT ADVOCACY | $30K | H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues. |
| 2026-04-19 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory |
| 2026-04-16 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | TCH GROUP, LLC | $30K | Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule) |
| 2026-04-15 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2026-04-09 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of War. Issues related to corporate taxation. |
| 2026-02-13 | COR | CENCORA | MONUMENT ADVOCACY | $0 | HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule. |
| 2026-01-20 | COR | CENCORA INC. | CENCORA, INC. | $1.9M | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages CMS Proposed Medicare Physician Fee Schedule Rule Proposed Changes to Bonafide Service Fees Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Strategic National Stockpile Essential Medicines Strategic Stockpile Department o |
| 2026-01-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2026-01-20 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $50K | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) |
| 2026-01-19 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Introductions & issues related to supply chains Issues related to health care and pharmaceutical industry |
| 2026-01-18 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico |
| 2026-01-16 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | TCH GROUP, LLC | $30K | Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule) |
| 2026-01-15 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2026-01-14 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of Defense. Issues related to corporate taxation. |
| 2026-01-13 | COR | CENCORA FKA AMERISOURCEBERGEN CORPORATION | HORIZON GOVERNMENT AFFAIRS | $50K | HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule |
| 2025-10-20 | COR | CENCORA INC. | CENCORA, INC. | $680K | One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI) Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduct |
| 2025-10-20 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Issues related to health care and pharmaceutical industry |
| 2025-10-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-10-20 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $50K | Recognizing pharmacists as providers within Medicare COVID-19 response Proposals relating to the Strategic National Stock Pile; COVID-19 vaccine distribution; H.R. 5376- Build Back Better Act; H.R 2870 Essential Medicines Strategic Stockpile Act of 2021-provisions related to medical supply chains and strategic stock piles; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages |
| 2025-10-16 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-10-16 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | TCH GROUP, LLC | $30K | Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule) |
| 2025-10-13 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands |
| 2025-10-09 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of Defense. Issues related to corporate taxation. |
| 2025-10-03 | COR | CENCORA FKA AMERISOURCEBERGEN CORPORATION | HORIZON GOVERNMENT AFFAIRS | $50K | HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule |
| 2025-07-21 | COR | CENCORA INC. | CENCORA, INC. | $760K | Ensuring Community Access to Pharmacist Services Act (H.R. 3164) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164) Impacts to pharmacy Part D drug pricing in IRA Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization Medical Supply Resiliency |
| 2025-07-21 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade |
| 2025-07-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-07-21 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $40K | Recognizing pharmacists as providers within Medicare COVID-19 response; H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2) H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); Proposals relating to the Strategic National Stock Pile; COVID-19 vaccine distribution; H.R. 5376- Build Back Better Act; H.R 2870 Essential Medicines Strategic Stockpile Act of 2021-provisions related to medical supply chains and strategic stock piles; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages |
| 2025-07-21 | COR | HARBINGER STRATEGIES LLC ON BEHALF OF CENCORA INC. | COLTON STREET GROUP | $0 | Issues related to Healthcare Reform. Business tax issues. |
| 2025-07-17 | COR | CENCORA INC. (FORMERLY KNOWN AS AMERISOURCEBERGEN) | DGA GROUP GOVERNMENT RELATIONS LLC (FORMERLY DENTONS GLOBAL ADVISORS GOVERNMENT | $0 | |
| 2025-07-16 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of Defense. Issues related to corporate taxation. |
| 2025-07-16 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-07-14 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands |
| 2025-07-13 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | TCH GROUP, LLC | $20K | Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services |
| 2025-07-01 | COR | CENCORA FKA AMERISOURCEBERGEN CORPORATION | HORIZON GOVERNMENT AFFAIRS | $50K | Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; Act; Seniors' Access to Critical Medications Act (H.R. 2484); HR1, the One Big Beautiful Bill Act; HHS - drug pricing issues, implementation of Inflation Reduction Act. |
| 2025-05-22 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $0 | Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform |
| 2025-04-21 | COR | CENCORA INC. | CENCORA, INC. | $450K | The Equitable Community Access to Pharmacist Services Act Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act Seniors Access to Critical Medicines Act (H.R. 2484) Protecting Patient Access to Cancer and Complex Therapies Act Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Pharmacy and Medically Underserved Area Enhancement Act Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act Seniors Access to Critical Medications Act (H.R. 2484) Strategic National Stockpile. Essential Medicines Strategic Stockpile Act Prescription Information Modernization Act Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response A |
| 2025-04-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. Tax reconciliation legislation (No Bill Number): issues related to the tax treatment of the LIFO inventory valuation method. General monitoring of business tax issues. The FY2026 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-04-21 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $40K | Recognizing pharmacists as providers within Medicare COVID-19 response; H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2) H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); Proposals relating to the Strategic National Stock Pile; COVID-19 vaccine distribution; H.R. 5376- Build Back Better Act; H.R 2870 Essential Medicines Strategic Stockpile Act of 2021-provisions related to medical supply chains and strategic stock piles; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages |
| 2025-04-21 | COR | HARBINGER STRATEGIES LLC ON BEHALF OF CENCORA INC. | COLTON STREET GROUP | $30K | Issues related to Healthcare Reform. Business tax issues. |
| 2025-04-18 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-04-17 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | TCH GROUP, LLC | $20K | Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services |
| 2025-04-14 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of Defense. Issues related to corporate taxation. |
| 2025-04-14 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory |
| 2025-04-14 | COR | CENCORA INC. (FORMERLY KNOWN AS AMERISOURCEBERGEN) | DGA GROUP GOVERNMENT RELATIONS LLC (FORMERLY DENTONS GLOBAL ADVISORS GOVERNMENT RELATIONS LLC) | $30K | Health care product supply chain issues and Strategic National Stockpile |
| 2025-04-07 | COR | CENCORA FKA AMERISOURCEBERGEN CORPORATION | HORIZON GOVERNMENT AFFAIRS | $50K | Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526). |
| 2025-01-21 | COR | CENCORA INC. | CENCORA, INC. | $1.1M | Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical |
| 2025-01-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. General monitoring of business tax issues. The FY2025 National Defense Authorization Act (H.R. 8070): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-01-21 | COR | CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | BALLARD SPAHR LLP | $50K | Recognizing pharmacists as providers within Medicare COVID-19 response; H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); H.R. 2670-National Defense Authorization Act For Fiscal Year 2024; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); Proposals relating to the Strategic National Stock Pile; COVID-19 vaccine distribution; H.R. 5376- Build Back Better Act; H.R 2870 Essential Medicines Strategic Stockpile Act of 2021-provisions related to medical supply chains and strategic stock piles; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages |
| 2025-01-21 | COR | HARBINGER STRATEGIES LLC ON BEHALF OF CENCORA INC. | COLTON STREET GROUP | $50K | Issues related to Healthcare Reform. Business tax issues. |